Back
Eli Lilly and Vs. Viking Therapeutics Industry Stock Comparison
Buy
56
LLY
Eli Lilly and
Last Price:
733.32
Seasonality Move:
3.18%
Buy
67
VKTX
Viking Therapeutics
Last Price:
74.28
Seasonality Move:
18.5%
Buy
56
Eli Lilly and (LLY)
is a Buy
Is Eli Lilly and a Buy, Sell or Hold?
- The current Eli Lilly and [LLY] share price is $733.51. The Score for LLY is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
- LLY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
67
Viking Therapeutics (VKTX)
is a Buy
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $74.31. The Score for VKTX is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
- VKTX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LLY Stock Price Chart
What is Eli Lilly and's stock price today?
-
The Eli Lilly and share price today is $733.51
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LLY is experiencing buying pressure, which is a positive indicator for future bullish movement.
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $74.31
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LLY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -7.76 | Sell |
| Relative Strength Index (14 RSI): | 42.89 | Sell |
| Chaikin Money Flow: | 1041343 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (739.45 - 774.43) | Sell |
| Bollinger Bands (100): | (618.48 - 771.72) | Buy |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 58.75 | Buy |
| Chaikin Money Flow: | 3146467 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (65.96 - 77.78) | Buy |
| Bollinger Bands (100): | (18.89 - 70.61) | Buy |
LLY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 736.33 | Sell |
| 20-day SMA: | 752.43 | Sell |
| 50-day SMA: | 761.34 | Sell |
| 200-day SMA: | 622.61 | Buy |
| 8-day EMA: | 736.95 | Sell |
| 20-day EMA: | 747.27 | Sell |
| 50-day EMA: | 741.12 | Sell |
| 200-day EMA: | 632.53 | Buy |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 66.46 | Buy |
| 20-day SMA: | 70.59 | Buy |
| 50-day SMA: | 68.11 | Buy |
| 200-day SMA: | 28.71 | Buy |
| 8-day EMA: | 68.34 | Buy |
| 20-day EMA: | 68.99 | Buy |
| 50-day EMA: | 63.17 | Buy |
| 200-day EMA: | 36.96 | Buy |
Eli Lilly and Earnings Growth & LLY Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.58 per share, an increase next quarter of $0.02 per share, an increase this year of $6.18 per share, and an increase next year of $5.66 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.01 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.41 per share.
Eli Lilly and Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||